Formulation and Drug Delivery

Abzena Signs Antibody Manufacturing Development Agreement with UCL

February 21, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Under the agreement, Abzena will manufacture magacizumab, an antibody created using the ‘Abzena inside’ Composite Human Antibody technology.

Past, Present, and Future Trends Affecting the Bio/Pharmaceutical Industry

February 17, 2017

The trends in the year 2017 will present the industry with new challenges, and companies will be able to meet them successfully if they focus on the issues at hand.

Symbiosis Announces Plans to Open US Office

February 16, 2017

The new commercial site, set to be located in Cambridge, Boston, MA, will serve clients on both the East and West Coast. It will also be the base for reaching new customers in the area.

EDQM Clarifies the Role of Monographs in Determining Biosimilarity

February 15, 2017

The directorate says monographs are flexible and changeable and their compliance does not on its own determine biosimilarity in biosimilars.

Aurobindo Adds Four Biosimilars From TL Biopharmaceutical

February 14, 2017

Aurobindo has added four cell-culture derived biosimilars to its product line.

GPhA Rebrands as AAM

February 14, 2017

The Generic Pharmaceutical Association announces a rebranding campaign to expand access to medicines.

Therapeutic Antibodies to Track in 2017, Part I

February 13, 2017

EvaluatePharma and BioPharm International highlight the antibody-based therapeutics that may gain United States Regulatory approval in 2017.

Dr. Reddy's Expands European Operations

February 08, 2017

Dr. Reddy’s has expanded its commercial operations in Europe with the introduction of its range of generic drugs in France.

Capsugel Announces Commercial Availability of Modular Automated Sampling Technology

February 08, 2017

Modular Automated Sampling Technology (MAST) allows direct aseptic transfer of bioreactor samples to analytical devices, providing rapid and reliable data in bioprocessing.

Austrian Centre of Industrial Biotechnology and GE Healthcare Form Cell Line Engineering Pact

February 07, 2017

This three-year partnership will explore and identify new tools and methods to modify and optimize the Chinese hamster ovary (CHO) cell line performance.